B. V. van Engelen
发表
J. Goeman,
S. Anvar,
P. ’. ‘t Hoen,
2013,
Aging.
J T den Dunnen,
C T Verrips,
J. T. Dunnen,
2003,
Journal of immunological methods.
R. Frants,
R. Lemmers,
R. Tawil,
2009,
Human mutation.
R. Foisner,
J. Harborth,
J. Broers,
2007,
The Journal of cell biology.
R. Wevers,
S. Wopereis,
E. Morava,
2007,
Clinical chemistry.
C. Sweep,
P. Span,
C. Tack,
2002,
The Journal of clinical endocrinology and metabolism.
H. Worman,
B. V. van Engelen,
G. Bonne,
2006,
Biochemical and biophysical research communications.
B. Wieringa,
A. González-Barriga,
J. Kranzen,
2014,
Neuromuscular Disorders.
M. Lamers,
V. Kimonis,
A. Ferlini,
2019,
Journal of Medical Genetics.
Zizhen Yao,
S. Tapscott,
Janet M. Young,
2013,
PLoS genetics.
D. Lefeber,
B. V. van Engelen,
A. Willems,
2016,
Biochimica et biophysica acta.
Moses Rodriguez,
B. V. van Engelen,
K. Pavelko,
1998,
The Journal of Neuroscience.
F. Baas,
D. Henderson,
N. Voermans,
2018,
Human molecular genetics.
L. Ronco,
J. Statland,
O. D. Leinhard,
2022,
Neurology.
Dominant mutations in KBTBD13, a member of the BTB/Kelch family, cause nemaline myopathy with cores.
F. Mastaglia,
H. Kremer,
G. Ravenscroft,
2010,
American journal of human genetics.
S. Blumen,
C. Ottenheijm,
G. Butler-Browne,
2022,
Acta Neuropathologica.